ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Infectious Disease

Top Infectious Disease Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GUL MADISON M.D.

Infectious Disease

10,794

$623K

420
248 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 46%

$58
Average prescription price

Avg: $320

ARTHUR WILLIAMS MD

Infectious Disease

8,164

$882K

420
124 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 46%

$108
Average prescription price

Avg: $320

ROBERT SULLIVAN M.D.

Infectious Disease

7,114

$641K

297
242 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 46%

$90
Average prescription price

Avg: $320

MELINA IRIZARRY-ACOSTA MD

Infectious Disease

6,633

$364K

440
293 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 46%

$55
Average prescription price

Avg: $320

BONNIE VAN UITERT M.D.

Infectious Disease

6,215

$1.58M

152
56 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 46%

$255
Average prescription price

Avg: $320

JAY KOSTMAN MD

Infectious Disease

6,197

$2.99M

171
49 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 46%

$483
Average prescription price

Avg: $320

KARAM MOUNZER MD

Infectious Disease

5,677

$2.34M

130
11 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 46%

$412
Average prescription price

Avg: $320

ZAHIDA BHATTI MD

Infectious Disease

5,488

$536K

275
88 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 46%

$98
Average prescription price

Avg: $320

MARGARET HOFFMAN-TERRY MD

Infectious Disease

5,228

$1.67M

88
15 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

28%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 46%

$319
Average prescription price

Avg: $320

LISA TKATCH MD

Infectious Disease

5,022

$1.63M

1546
1291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 46%

$324
Average prescription price

Avg: $320

MOHAMMAD BARI M.D.

Infectious Disease

4,401

$242K

223
195 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 46%

$55
Average prescription price

Avg: $320

TIMOTHY FRIEL MD

Infectious Disease

3,990

$1.62M

89
0 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 46%

$406
Average prescription price

Avg: $320

MEREDITH SCHADE M.D.

Infectious Disease

3,501

$219K

242
139 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 46%

$63
Average prescription price

Avg: $320

CHIU-BIN HSIAO M.D.

Infectious Disease

3,434

$1.44M

126
16 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

37%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 46%

$420
Average prescription price

Avg: $320

MARCELO GARECA MD

Infectious Disease

3,338

$1.25M

122
30 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 46%

$375
Average prescription price

Avg: $320

ANDREW SAHUD MD

Infectious Disease

3,104

$1.36M

159
22 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 46%

$439
Average prescription price

Avg: $320

JOSEPH YOZVIAK D.O.

Infectious Disease

2,847

$1.55M

99
11 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 46%

$543
Average prescription price

Avg: $320

JOHN ZURLO MD

Infectious Disease

2,663

$1.55M

123
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 46%

$583
Average prescription price

Avg: $320

MICHAEL SILVERMAN M.D.

Infectious Disease

2,308

$892K

69
33 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 46%

$387
Average prescription price

Avg: $320

STACY LANE DO

Infectious Disease

2,268

$734K

106
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 46%

$324
Average prescription price

Avg: $320

IAN FRANK MD

Infectious Disease

2,078

$1.04M

48
0 are 65+

31%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 46%

$502
Average prescription price

Avg: $320

JOHN GOLDMAN MD

Infectious Disease

2,030

$971K

158
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 46%

$479
Average prescription price

Avg: $320

EVAN BELL M.D.

Infectious Disease

2,017

$360K

200
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 46%

$179
Average prescription price

Avg: $320

HELEN KOENIG MD

Infectious Disease

1,949

$785K

81
0 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 46%

$403
Average prescription price

Avg: $320

LAURA BAMFORD MD

Infectious Disease

1,912

$1.04M

122
0 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 46%

$544
Average prescription price

Avg: $320

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank